Monday, September 14, 2026

Korea Drug Development Fund Shifts Focus Toward Global Capital, Collaboration, and Commercialization

KDDF aims to enhance its role as a connection platform to expand global bio investment and collaboration.

North Korea Cultivating ‘Memory Masters’… Propagandizing Achievement of Renewing ‘World Memory Record’

North Korea is focusing on mental sports, training athletes like Yang Jeong Hee to excel in memory competitions and techniques.

Coupang Controversy: Will U.S. Intervention Spark a Trade War Between Korea and America?

U.S. investors demand U.S. intervention in Coupang's data breach, alleging South Korea's discrimination, which could escalate trade tensions.

Tag: R&D

SK Biopharm’s Bold Move: How MD Expertise is Shaping Global Drug Development in 2026

SK Biopharm is enhancing its global competitiveness in drug development by establishing a specialized R&D system for new drug candidates.

Daewoong Pharmaceutical Wins Seoul Biohealth Award: How Open Innovation is Transforming R&D in 2026

Daewoong Pharmaceutical received recognition for its R&D and open innovation collaboration at the 1st Seoul Biohealth Awards.

Korea Rising: How South Korea is Shaping the Future of the Global Bioindustry at BIO International Convention 2026

Korea's bioindustry showcased its innovations at BIO USA 2026, emphasizing global collaboration and the need for diverse business models.

[Lillie report] Lilly’s Pacific-facing innovation hub brings K-biotech future to Songdo

Lilly Gateway Labs in San Diego supports early-stage biotechs, expanding to Korea with Samsung Biologics to foster innovation.

Dong-A ST Eyes Early-Stage Licensing Deals as Key Growth Strategy, Says VP Oh Yoon-seok [BIO USA]

Dong-A ST aims for global expansion by licensing preclinical drug candidates, focusing on timely execution of R&D strategies by 2027.

Cha Biotech Announces Support of K-Bio Startups at Bio Korea 2026

Cha Biotech aims to create a global innovation ecosystem for K-Bio startups through the K-Bio CIC Open Innovation Center.

How the 2026 Drug Price Reform Will Reshape the Pharmaceutical Industry

Experts discuss the impact of drug pricing reform on the pharmaceutical sector, urging innovation and strategic shifts in R&D investments.

Samjin Pharm Selected as Leading Biotech Firm in Government-Backed ‘World Class Plus’ Project

Samjin Pharm selected for the "World Class Plus Project" to enhance global competitiveness in biotech with innovative drug developments.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

SK Nexilis to Showcase 4-Micrometer Ultra-Wide Copper Foil at InterBattery 2026

SK Nexilis will showcase innovative copper foil technology at InterBattery 2026, enhancing productivity for battery manufacturers.

Future of EV Batteries—Dongwha Electrolyte’s R&D Roadmap Revealed

Dongwha Electrolyte will present its R&D roadmap and strategies for global battery regulations at InterBattery 2026 in Seoul.

Can Samjin Pharm Overcome Generic Drug Price Cuts With AI-Driven Drug Development?

Samjin Pharm shifts focus to R&D, moving away from generics to innovative drug development, amid government price cuts.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

Chinese & Indian Medical Invasion: Pharmaceutic Dependency on Risk of Essential Medicine Supply

Concerns rise over South Korea's API industry reliance on China and India, with self-sufficiency at a record low of 25.6% in 2023.

Top News

- Our Sponsors Ad -

Follow us